Effect of quinine on the multidrug resistance and intracellular distributin of THP-DOX in LR73 tumor cells: Comparative study with verapamil and S9788 by confocal laser microspectrofluorometry;Effet de la quinine sur la resistance multiple et la distribution intracellulaire de la pirarubicine dans les cellules tumorales LR73: Etude comparative avec le verapamil et le S9788 par microspectrofluorimetrie confocale laser

Bulletin du Cancer

Volumn 84, Issue 4, 1997, Pages 343-349

  Belhoussine, Rajae ^a   Morjani, Hamid ^a   Manfait, Michel ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

anthracycline; cellular distribution; microspectrofluorometry; multidrug resistance; Pgp; reversal

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; GLYCOPROTEIN P; PIRARUBICIN; QUININE; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CHO CELL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; MULTIDRUG RESISTANCE; NONHUMAN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CRICETINAE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; MICROSCOPY, CONFOCAL; P-GLYCOPROTEIN; PIPERIDINES; QUININE; SPECTROMETRY, FLUORESCENCE; TRIAZINES; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0030983598     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants. Biochim Biophys Acta 1976 ; 455 : 152-62.
2. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 1993 ; 62 : 385-427.
3. Thiebaut F, Currier SJ, Whitaker J, Haugland RP, Gottesman MM, Pastan I, Willingham MG. Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye. J Histochem Cytochem 1990 ; 38 : 685-90.
4. Roepe PD. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry 1992 ; 31 : 12555-64.
5. Schindler M, Grabski S, Hoff E, Simon SM. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). Biochemistry 1996 ; 35 : 2811-7.
6. Jardillier JC, Colin M, Bobichon H, Akeli MG, Delvincourt C, Madoulet C. Le phénotype de résistance multidrogue: quelques caractéristiques morphologiques et biologiques autres que la pompe à efflux. Bull Cancer 1994 ; 81 : 392-9.
7. Bellamy WT, Dalton WS, Dorr RT. The clinical relevance of multidrug resistance. Cancer Inv 1990 ; 8 : 547-62.
8. O'Brien ML, Tew KD. Glutathione and related enzymes in multidrug resistance. Eur J Cancer 1996 ; 32A : 967-78.
9. Tsuruo T, Lida H, Tsukagoshi S, Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981 ; 41 : 1967-72.
10. Bennis S, Ichas F, Robert J. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line. Int J Cancer 1995 ; 62 : 283-90.
11. Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, Willingham MC. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter. Mol Pharmacol 1991 ; 40 : 490-4.
12. Georges E, Sharom FJ, Ling V. Multidrug resistance and chemosensitization. Therapeutic implications for cancer chemotherapy. Adv Pharmacol 1990 ; 21 : 185-220.
13. Sonneveld P, Durie BGM, Lokhorst HM, Marie JP, Solbu G, Suciu S, et al. Modulation of multidrug-resistant multiple myeloma by cyclosporine. Lancet 1992 ; 340 : 255-9.
14. Merlin JL, Marchai S, Ramacci C, Diterlen A, Schultz G, Lucas C, et al. Influence of S9788, a new modulator of multidrug resistance, on cellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells. Cytometry 1995 ; 20 : 315-23.
15. Bates SE, Lee JS, Dickstein B, Spolyar M, Fojo AT. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 1993 ; 32 : 9156-64.
16. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemia cells. Mol Pharmacol 1988 ; 33 : 454-62.
17. Allison AC, Young MR. Uptake of dyes and drugs by living cells in culture. Life Sci 1964 ; 3 : 1407-12.
18. Bennis S, Robert J. Effets différentiels du S9788, du vérapamil et de la quinine sur la réversion de la multidrug résistance dans deux lignées tumorales humaines. Bull Cancer 1994 ; 81 : 886-90.
19. Gigli M, Doglia S, Millot JM, Valentini L, Manfait M. Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry. Biochim Biophys Acta 1988 ; 950 : 13-20.
20. Gigli M, Rasoanaivo TWD, Millot JM, Jeannesson P, Rizzo V, Jardillier JC, et al. Correlation between growth inhibition and intranuclear doxorubicin and 4′-iododoxorubicin quantitated in living K562 cell by microspectrofluorometry. Cancer Res 1989 ; 49 : 560-4.
21. Sebille S, Morjani H, Poullain MG, Manfait M. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry. Anticancer Res 1994 ; 14 : 2389-94.
22. De Duve C, DeBarsyi T, Poole B, Trouet A, Tulkens P, Van Houf F. Lysosomotropic agents. Biochem Pharmacol 1974 ; 23 : 2495-531.
23. Ramu A, Zuks Z, Gatt S, Glaubiger D. Reversal of acquiered resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Cancer Res 1984 ; 44 : 144-8.
24. Garcia ML, Trumble MJ, Reuben JP, Kauzorowsky GJ. Characterization of verapamil binding sites in cardiac membrane vesicles. J Biol Chem 1984 ; 259 : 15013-6.
25. Slater LM, Sweet P, Stupecky M, Gupta S. Cyclosporine A reverses vincristine and daunorubicin resistance in acute lymphocytic leukemia in vitro. J Clin Invest 1986 ; 77 : 1405-8.
26. Jaffrézou JP, Levade T, Chatelin P, Laurent G. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer {{2-isopropyl- 1 -{4-[3-N-methyl- N -(3,4-dimethoxy-β-phenethyl) amino] propyloxy} -benzenesulfonyl}}indolizine. Cancer Res 1992 ; 52 : 6440-6.
27. Millot JM, Sharonov S, Manfait M. Scanning microspectrofluorometry of rhodamine 123 in multidrug-resistant cells. Cytometry 1994 ; 17 : 50-8.
28. Millot JM, Joly P, Benoist H, Manfait M. Doxorubicin nuclear distribution necessary to induce erythroid differentiation of K562 cells. J Cell Pharmacol 1991 ; 2 : 1-8.
29. Tritton TR. Cell surface actions of adriamycin. Pharmacol Ther 1991 ; 49 : 293-309.
30. Jaffrézou JP, Levade T, Bettaieb A, Andrieu N, Bezombes C, Maestre N, et al. Daunorubicin-induced apoptosis : triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 1996 ; 15 : 2417-24.
31. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis : an alternative mechanism for generating death signals. Cell 1995 ; 82 : 504-14.
32. Escriba PV, Sastre M, Garcia-Sevilla JA. Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures. Proc Natl Acad Sci USA 1995 ; 92 : 7595-9.
33. Le Moyec L, Tatoud R, Degeorges A, Calabresse C, Bauza G, Eugene M, Calvo F. Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. Cancer Res 1996 ; 56 : 3461-7.
34. Lavie Y, Cao HT, Bursten SL, Giuliano AE, Cabot MC. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 1996 ; 271 : 19530-6.
35. Escriba PV, Ferrer-Montiel AV, Ferragut JA, Gonzalez-Ros JM. Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug resistance phenomena. Biochemistry 1990 ; 29 : 7275-82.
36. Jaffrézou JP, Chen G, Duran GE, Muller C, Bordier C, Laurent G, et al. Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochim Biophys Acta 1995 ; 1266 : 1-8.
37. Pajeva IK, Wiese M, Cordes HP, Seydel JK. Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability. J Cancer Res Clin Oncol 1996 ; 122 : 27-40.
38. Gros P, Ben Neriah Y, Croop J, Housman DE. Isolation and expression of complementary DNA that confers multidrug resistance. Nature 1986 ; 323 : 728-31.
39. Pignon B, Morjani H, Vilque JP, Millot JM, Simon G, Lartigue B, et al. In vitro study of THP-doxorubicin retention in human leukemic cells using confocal microspectroflurometry. Leukemia 1995 ; 9 : 1361-7.